|
Top : For Professionals Only : Antibiotics
CF Resources: For Professionals Only : Antibiotics
Links:
- Macrolide Antibiotics and Cystic Fibrosis (2002)
- Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis
(Added: 23-Oct-2002 Hits: 137 Rating: 0 ) Rate It
- Tobi Approved In Canada For Cystic Fibrosis (1999)
- Health Canada’s Therapeutic Products Programme has approved PathoGenesis Canada Ltd.’s Tobi(TM) (tobramycin solution for inhalation) for the management of cystic fibrosis (CF) patients with chronic pulmonary Pseudomonas aeruginosa infections.
(Added: 2-Dec-2002 Hits: 180 Rating: 0 ) Rate It
- Tobi Can Save Money For Canadian CF Patients (1999)
- June 11, 1999 -- Results of a Canadian cystic fibrosis study show that Tobi (tobramycin solution for inhalation) can save $4,055 CDN per patient in a 24-week period compared to patients who are not receiving nebulised antibiotics.
(Canada)
(Added: 23-Oct-2002 Hits: 188 Rating: 0 ) Rate It
Pages Updated On: 2-Sep-2009 - 15:28:35
Links Engine 2.0 By: Gossamer Threads Inc.
The Cystic Fibrosis-Reaching Out Foundation is a non-profit Foundation under Section 501 (c) 3 of the Internal Revenue Code. Accordingly, the Foundation is not required to pay income taxes. Donors may deduct contributions to the Cystic Fibrosis-Reaching Out Foundation Inc, only to the extent that their contributions are gifts, with no consideration given.
|
